Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the study page to improve context and access to relevant resources.
    Difference
    0.1%
    Check dated 2026-03-26T11:48:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Removed the term 'Multiple Myeloma' and a related topic, and added a new page revision label 'Revision: v3.5.0' (replacing 'Revision: v3.4.3').
    Difference
    0.1%
    Check dated 2026-03-19T06:02:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and linked MedlinePlus Genetics. Updated the site revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:14:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' content and the related MedlinePlus Genetics links from the page.
    Difference
    0.1%
    Check dated 2026-03-04T23:37:34.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Related topics now include Multiple myeloma and a MedlinePlus Genetics link.
    Difference
    0.1%
    Check dated 2026-02-25T18:52:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page no longer displays the disease name 'Multiple myeloma' or its related topics. This reduces disease context and discoverability for the trial.
    Difference
    0.1%
    Check dated 2026-02-18T16:34:33.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.